Board of Directors

Michael Singer

Chairman of the Board of Directors, Warnex Inc.
Chief Financial Officer and Corporate Secretary, Thallion Pharmaceuticals Inc.

Mr. Singer has been Chief Financial Officer and Corporate Secretary of Thallion Pharmaceuticals Inc. since March 2007. Prior to Thallion, he served as Vice President, Chief Financial Officer and Corporate Secretary of Caprion Pharmaceuticals Inc. from February 2000 until its merger with Ecopia BioSciences Inc. to form Thallion in 2007.

Marc LeBel

Interim Chief Executive Officer, Warnex Inc.

Dr. LeBel is currently Director of Acasti Pharma Inc., a member of the Advisory Committee of JustBio, Executive Producer of the film "Ruby McCollum", and Associate Producer of the 3D animation movie "Sarila". He is the founder of Anapharm Inc. and served as the company's President from 1994 to 2007. Dr. LeBel was Executive Vice-President of Pharmanet, from 2005 to 2007, following its acquisition of Anapharm.

Louis Lacasse

President, Genechem Management Inc.

Mr. Lacasse has been President of GeneChem Management Inc. since 1997 and Managing Partner of AgeChem Financial Inc. since 2006. Mr. Lacasse is currently on the boards of directors of Methylgene Inc. and Calyx Bioventures. He has previously served on the boards of directors of many private and public companies including BioChem Pharma Inc., Axcan Pharma Inc., Targeted Genetics Inc., and Idun Pharmaceuticals Inc.

Patrice Hugo

Chief Scientific Officer, Clearstone Central Laboratories

Dr. Patrice Hugo has more than 20 years of experience in biomarkers including in the fields of discovery and validation as well as in diagnostic product development. Since 2009, he has been Chief Scientific Officer of Clearstone Central Laboratories, following the spin-off of a business unit of MDS Pharma Services to Global Central Laboratories where he held the position of Vice-President Scientific Affairs since 2008. From 2003 to 2008, Dr. Hugo held various senior roles at Caprion from Executive Director to Executive Vice President Research and Development. From 1997 to 2003, Dr. Hugo worked at PROCREA BioSciences, first as Vice President of Scientific Research and then as Chief Scientific Officer. From 1994 to 1997, he worked as a Principal Investigator at the Institut de Recherches Cliniques de Montréal. Dr. Hugo holds a PhD in Experimental Medicine from McGill University.

Joseph Walewicz

Consultant

Mr. Joseph Walewicz was Vice-President, Special Projects and COO of Paladin Biosciences between 2009 and 2011. Between 2005 and 2008, Mr. Walewicz was Executive Director, Institutional Equity Research at CIBC World Markets. Mr. Walewicz holds a Master of Business Administration, Finance, a Bachelor of Science, Biochemistry, and a Bachelor of Arts, Economics. Mr. Walewicz is also a CFA (Chartered Financial Analyst) charter holder.